PA
NUS icon

PharVision Advisers’s Nu Skin NUS Stock Holding History

PharVision Advisers’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.7K Buy
+13,202
New +$84.4K 1.31% 45
2025
Q1 		– Sell
-81,429
Closed -$561K – 445
2024
Q4 		$561K Buy
+81,429
New +$560K 0.47% 28

Other funds holding NUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's NUS Position: Q2 2026 in Review

PharVision Advisers opened a new position in Nu Skin (NUS) in Q2 2026: 13,202 shares worth $69.7K. The stake represents 1.31% of the portfolio and ranks #45 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in NUS as recently as Q4 2024.

PharVision Advisers first reported a position in NUS in Q4 2024 and has held it in 2 quarters since. The position peaked at $561K in Q4 2024. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • PharVision Advisers held 13,202 shares of Nu Skin worth $69.7K as of Q2 2026.
  • Nu Skin was a new PharVision Advisers position in Q2 2026.
  • Nu Skin made up 1.31% of PharVision Advisers's portfolio in Q2 2026, its #45 holding.
  • PharVision Advisers first reported a position in Nu Skin in Q4 2024 and has held it in 2 quarters since.
  • PharVision Advisers's Nu Skin position peaked at $561K in Q4 2024.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.